Abstract
In the Original Article by Dikci et al. “The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/ Syndrome” (Endocr Metab Immune Disord Drug Targets. 2019; 19(2):166-170) after publication of the article it has come to the corresponding author's attention that there were some errors in the article. In the introduction section, reference 3 should be changed as reference 2 (paragraph 1, line 4) and references 4-6 should be changed as references 3-6 (paragraph 1, lines 6,7). Reference numbers in the references section should be as follows. References 25-28 should be changed as references 7-10 respectively. References 7-24 should be changed as references 11-28 respectively.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome
Volume: 19 Issue: 5
Author(s): Seyhan Dikci*, Emrah Öztürk, Penpe Gül Fırat, Turgut Yılmaz, Mehmet Çağatay Taşkapan and Saim Yoloğlu
Affiliation:
- Inonu Universiy Turgut Ozal Medical Center, Department of Ophthalmology, Malatya,Turkey
Abstract: In the Original Article by Dikci et al. “The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/ Syndrome” (Endocr Metab Immune Disord Drug Targets. 2019; 19(2):166-170) after publication of the article it has come to the corresponding author's attention that there were some errors in the article. In the introduction section, reference 3 should be changed as reference 2 (paragraph 1, line 4) and references 4-6 should be changed as references 3-6 (paragraph 1, lines 6,7). Reference numbers in the references section should be as follows. References 25-28 should be changed as references 7-10 respectively. References 7-24 should be changed as references 11-28 respectively.
Export Options
About this article
Cite this article as:
Dikci Seyhan *, Öztürk Emrah , Fırat Gül Penpe , Yılmaz Turgut , Taşkapan Çağatay Mehmet and Yoloğlu Saim , Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome, Endocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19 (5) . https://dx.doi.org/10.2174/187153031905190701170237
DOI https://dx.doi.org/10.2174/187153031905190701170237 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sibutramine Effects on Central Mechanisms Regulating Energy Homeostasis
Current Neuropharmacology Epigenetic and Genetic Mechanisms of Abnormal 11p15 Genomic Imprinting in Silver-Russell and Beckwith-Wiedemann Syndromes
Current Medicinal Chemistry Glucagon Like Peptides-1 Modulators as Newer Target for Diabetes
Current Drug Targets Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables
Mini-Reviews in Medicinal Chemistry Angiotensin-TGF-β1 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages
Current Pharmaceutical Design The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Aldose Reductase in the Retina
Current Enzyme Inhibition The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Current Pharmaceutical Design Spray Dried Plasma for Pigs Weaned at Different Ages
Recent Patents on Food, Nutrition & Agriculture ABC Transporters, Bile Acids, and Inflammatory Stress in Liver Cancer
Current Pharmaceutical Biotechnology Antifungal Agents in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Anti-Cancer Agents in Medicinal Chemistry Ghrelin Receptor Signaling: A Promising Therapeutic Target for Metabolic Syndrome and Cognitive Dysfunction
CNS & Neurological Disorders - Drug Targets Lipoproteins, Stroke and Statins
Current Vascular Pharmacology Preface
Current Pharmaceutical Design Assessing Drug Transport Across the Human Placental Barrier: From In Vivo and In Vitro Measurements to the Ex Vivo Perfusion Method and In silico Techniques
Current Pharmaceutical Biotechnology Metabolic Signaling to the Central Nervous System: Routes Across the Blood Brain Barrier
Current Pharmaceutical Design The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Current Drug Targets The Metabolic Syndrome From Pathophysiology to Novel Treatment Strategies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Epigenetic Modification in Neuropathic Pain
Current Pharmaceutical Design